| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6896888 Comprises Bacillus Calmette-Guerin (BCG) formulated with keratolytic agent (salicyclic acid) for topical application |
| 05/24/2005 | CA2210708C Tricyclic vasopressin antagonists |
| 05/24/2005 | CA2155840C Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004106934A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 05/19/2005 | WO2004016764A3 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 05/19/2005 | US20050108785 Using nuclear transplantation as tool in generating transgenic cells for treatment and prevention of liver, nervous system, cardiovascular and bone disorders; regenerative medicine |
| 05/19/2005 | US20050107611 For use as adenosine receptor ligands; immunostimulants; contraceptives |
| 05/19/2005 | US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107427 Benzyl urea and thiourea derivatives |
| 05/19/2005 | US20050107390 i.e. 7-[(3R)-3-Amino-4-(3,4-difluorophenyl)butanoyl]-3-methyl-6-(phenylmethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine, dihydrochloride; antilipemic, antiobesity |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107372 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/19/2005 | US20050107354 Preventive or therapeutic agent for kidney disease |
| 05/19/2005 | US20050107353 Methods of treating lower urinary tract disorders using losigamone |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106675 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/19/2005 | US20050106638 Immunoglobulin for use in diagnosis, prevention and treatment of fibrosis and scarring; antiscarring agents |
| 05/19/2005 | US20050106614 Reagents and methods useful for detecting diseases of the prostate |
| 05/19/2005 | US20050106235 Nsaid formulation comprising a granular composition and an extra-granular composition |
| 05/19/2005 | US20050106234 Calcium formate for use as a dietary supplement |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106127 Graft to humans; culture product; removing cells; preservation |
| 05/19/2005 | CA2543489A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof |
| 05/18/2005 | EP1530632A2 Growth factor which acts through erb b-4 rtk |
| 05/18/2005 | EP1530582A2 Diagnosis of kidney damage and protection against same |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 05/18/2005 | EP1530476A1 Use of reboxetine for the treatment of hot flashes |
| 05/18/2005 | EP1530473A2 Regulation of erythrocyte apoptosis |
| 05/18/2005 | EP1436381B1 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617879A 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617857A 2'-halo-3', 5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivative and the use thereof as a drug for curing urinary incontinence |
| 05/18/2005 | CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 05/18/2005 | CN1617743A New pharmaceutical combinations for nos inhibitors |
| 05/18/2005 | CN1617721A Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1616386A Intermediate for preparing isothiazole derivatives |
| 05/18/2005 | CN1616091A Compound protease medicine for treating prostate proliferation and its preparing method |
| 05/18/2005 | CN1616073A Chinese medicine preparation for invigorating liver and kidney and its preparing method |
| 05/18/2005 | CN1616030A Use of compound preparation in treating human hepatitis, cancer, diabetes and uremia |
| 05/18/2005 | CN1616022A Chinese medicine capsule for treating infection of urinary system and its preparing method |
| 05/18/2005 | CN1616003A Medicine for treating prostatitis |
| 05/18/2005 | CN1615998A Kidney tonifying capsule and its preparing method |
| 05/18/2005 | CN1615993A Chinese medicine for treating acute and chronic nephritis and uremia |
| 05/18/2005 | CN1615986A Chinese-western medicine compound suppository for treating prostatic diseases |
| 05/18/2005 | CN1615979A Jinluhuashi pill and powder |
| 05/18/2005 | CN1615975A Medicine for treating prostatosis |
| 05/18/2005 | CN1615974A Medicine for treating bed-wetting |
| 05/18/2005 | CN1615950A Chinese medicine sitting bathing preparation for treating chronic prostatitis and its preparing method and use |
| 05/18/2005 | CN1615932A Preparation for removing blood stasis keeping kidney essence |
| 05/18/2005 | CN1615925A Chinese medicine for treating nephritis |
| 05/18/2005 | CN1615920A Method for preparing medicine for treating chronic renal in sufficiency |
| 05/18/2005 | CN1615908A Absorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 05/18/2005 | CN1615891A Compound and use for the treatment of benign prostatic hyperplasia and relative diseases |
| 05/18/2005 | CN1615868A Cyclic dextrin inclusion compound of mintpress hydrochloride and its preparing method |
| 05/18/2005 | CN1615847A Use of scopoletin in preparing medicine for preventing and curing hyperuricemia |
| 05/18/2005 | CN1615843A Epicatechin-3-0-gallate and epigallocatechin -3-0-gallate for inhibiting chronic renal faillure |
| 05/18/2005 | CN1615833A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
| 05/18/2005 | CN1202093C Substituted heterocyclic compound |
| 05/18/2005 | CN1202067C Method for preparing medicinal grade ferric citrate |
| 05/18/2005 | CN1201809C Preparation of Chinese herbal medicine for removal of urinary calculus |
| 05/18/2005 | CN1201792C Chinese medicine prepn for treating nephropathy and its preparation |
| 05/18/2005 | CN1201785C Medicine for kidney reinforcing and beauty treatment |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/17/2005 | US6894188 Adrenergic nblocking agent; benign prostatic hyperplasma |
| 05/17/2005 | US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders |
| 05/17/2005 | US6894071 Medical compositions for intravesical treatment of bladder cancer |
| 05/17/2005 | US6894067 5-heteroatom-substituted pyrazoles |
| 05/17/2005 | US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases |
| 05/17/2005 | US6894058 Administering statin drug |
| 05/17/2005 | US6894053 Potentiators of serotonin reuptake inhibitors; cyclohexane carboxylic acid-((1r)-1-cyclohexylmethyl-2-(4-(2-methoxy phenyl)-piperazin-1-yl)ethyl)amide derivatives |
| 05/17/2005 | US6894052 Serotonergic receptor antagonist |
| 05/17/2005 | US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives |
| 05/17/2005 | US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 05/17/2005 | US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes |
| 05/17/2005 | US6894036 4-dedimethylaminotetracycline derivatives |
| 05/17/2005 | US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 05/17/2005 | US6893627 Method for treating type 2 diabetes with an extract of Artemisia |
| 05/17/2005 | CA2350061C New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 05/17/2005 | CA2267510C Process for manufacturing alpha-1l-adrenoceptor antagonists |
| 05/12/2005 | WO2005042727A2 Methods of organ regeneration |
| 05/12/2005 | WO2003070903A3 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |